marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 10-30-2024
Processa Pharmaceuticals Retained Earnings 2011-2024 | PCSA
Annual Retained Earnings Processa Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -75.4 M | -64.2 M | -36.8 M | -25.4 M | -11 M | -7.62 M | -3.86 M | -15.3 M | -14.9 M | -12.9 M | -6.81 M | -3.43 M | -941 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -941 K | -75.4 M | -21.4 M |
Quarterly Retained Earnings Processa Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -84.5 M | -81.1 M | -75.4 M | -73 M | -70.9 M | -68.3 M | -64.2 M | -51.2 M | -45.2 M | -40.1 M | -36.8 M | -33.6 M | -30.7 M | -27.5 M | -25.4 M | -25.4 M | -25.4 M | -25.4 M | -11 M | -11 M | -11 M | -11 M | -7.62 M | -7.62 M | -7.62 M | -7.62 M | -3.86 M | -3.86 M | -3.86 M | -3.86 M | -2 M | -16.7 M | -15.3 M | -15.3 M | -14.9 M | -14.9 M | -14.9 M | -14.9 M | -11.8 M | -12.9 M | -12.9 M | -12.9 M | -6.81 M | -6.81 M | -6.81 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -2 M | -84.5 M | -25.6 M |